NCT03127709 A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03122522 A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03122509 A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer Status COMPLETED Phase PHASE2
NCT03122496 Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer Status COMPLETED Phase PHASE1
NCT03120676 Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT03119363 Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study) Status COMPLETED Phase NA
NCT03116997 Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant Status COMPLETED Phase PHASE3
NCT03114566 Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors Status TERMINATED Phase N/A
NCT03109977 Imaging With a New Agent That Finds a Cancer Protein Called HER2 Status COMPLETED Phase PHASE1
NCT03107416 Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03093922 A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03085173 A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03085147 A Dye for the Detection of Cancer of the Tongue and Mouth Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03085056 Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03082677 Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT03080948 Risk Stratification Among Individuals Who Have Many Moles on Their Skin Status COMPLETED Phase N/A
NCT03078010 Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03076164 A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib Status COMPLETED Phase PHASE1/PHASE2
NCT03070340 Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery Status COMPLETED Phase NA